These studies collectively suggest that an optimal concentration of HtrA3 during early pregnancy is necessary for the development of a functional placenta, and that HtrA3 may be a potentially useful biomarker for the early diagnosis/prediction of preeclampsia and IUGR [130]. This evidence concerns the gene HTRA3 and fetal growth restriction.